InsidersTradesSigma
Track the 동구바이오제약 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 동구바이오제약 has recorded 58 reports. Market capitalisation: €104.9bn. The latest transaction was reported on 15 July 2026 (Sale). Among the most active insiders: 조용준. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 58 declarations
Donggu Bio Pharmaceutical is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and manufacturing of pharmaceutical products.